164 related articles for article (PubMed ID: 23096234)
1. Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.
Saito I; Kario K; Kushiro T; Teramukai S; Zenimura N; Hiramatsu K; Kobayashi F; Shimada K
Hypertens Res; 2013 Feb; 36(2):177-82. PubMed ID: 23096234
[TBL] [Abstract][Full Text] [Related]
2. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.
Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Mori Y; Kobayashi F; Shimada K
Hypertension; 2014 Nov; 64(5):989-96. PubMed ID: 25156169
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.
Kushiro T; Kario K; Saito I; Teramukai S; Mori Y; Okuda Y; Shimada K
Hypertens Res; 2015 Mar; 38(3):178-85. PubMed ID: 25354777
[TBL] [Abstract][Full Text] [Related]
4. Home blood pressure and cardiovascular risk in treated hypertensive patients: the prognostic value of the first and second measurements and the difference between them in the HONEST study.
Saito I; Kario K; Kushiro T; Teramukai S; Yaginuma M; Mori Y; Okuda Y; Shimada K
Hypertens Res; 2016 Dec; 39(12):857-862. PubMed ID: 27488173
[TBL] [Abstract][Full Text] [Related]
5. Enhanced blood pressure-lowering effect of olmesartan in hypertensive patients with chronic kidney disease-associated sympathetic hyperactivity: HONEST study.
Kario K; Saito I; Kushiro T; Teramukai S; Mori Y; Hiramatsu K; Kobayashi F; Shimada K
J Clin Hypertens (Greenwich); 2013 Aug; 15(8):555-61. PubMed ID: 23889717
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
7. Effect of the angiotensin II receptor antagonist olmesartan on morning home blood pressure in hypertension: HONEST study at 16 weeks.
Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Hiramatsu K; Kobayashi F; Shimada K
J Hum Hypertens; 2013 Dec; 27(12):721-8. PubMed ID: 23863805
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
[TBL] [Abstract][Full Text] [Related]
9. 24-hour and nighttime blood pressures in type 2 diabetic hypertensive patients following morning or evening administration of olmesartan.
Tofé Povedano S; García De La Villa B
J Clin Hypertens (Greenwich); 2009 Aug; 11(8):426-31. PubMed ID: 19695030
[TBL] [Abstract][Full Text] [Related]
10. Reduction of the morning blood pressure surge treated with olmesartan in Chinese patients with mild to moderate essential hypertension--a multicenter, open-label, single treatment group clinical study.
Jiao Y; Ke Y; Sun N; Wang J; Deng W; Zhu J; ;
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):653-9. PubMed ID: 22774407
[TBL] [Abstract][Full Text] [Related]
11. Persistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study.
Kario K; Saito I; Kushiro T; Teramukai S; Yaginuma M; Mori Y; Okuda Y; Kobayashi F; Shimada K
Hypertens Res; 2016 May; 39(5):334-41. PubMed ID: 26739871
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study.
Matsui Y; O'Rourke MF; Hoshide S; Ishikawa J; Shimada K; Kario K
Hypertension; 2012 Jun; 59(6):1132-8. PubMed ID: 22547439
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of morning home blood pressure measurements in patients with type 2 diabetes mellitus: results of a 10-year, prospective, longitudinal study.
Kamoi K
Clin Exp Hypertens; 2015; 37(2):122-7. PubMed ID: 24786228
[TBL] [Abstract][Full Text] [Related]
14. Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study.
Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Kobayashi F; Shimada K
J Clin Hypertens (Greenwich); 2014 Jun; 16(6):442-50. PubMed ID: 24766515
[TBL] [Abstract][Full Text] [Related]
15. Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of Home blood pressure measurement with Olmesartan Naive patients to Establish Standard Target blood pressure (HONEST) study.
Saito I; Kario K; Kushiro T; Teramukai S; Yaginuma M; Zenimura N; Mori Y; Okuda Y; Shimada K
Clin Exp Hypertens; 2018; 40(5):407-413. PubMed ID: 29648464
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension.
Smolensky MH; Hermida RC; Portaluppi F
Chronobiol Int; 2007; 24(1):171-81. PubMed ID: 17364587
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study.
Ewald S; vor dem Esche J; Uen S; Neikes F; Vetter H; Mengden T
Clin Drug Investig; 2006; 26(8):439-46. PubMed ID: 17163276
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study.
Matsui K; Kim-Mitsuyama S; Ogawa H; Jinnouchi T; Jinnouchi H; Arakawa K;
Hypertens Res; 2014 Jun; 37(6):526-32. PubMed ID: 24599010
[TBL] [Abstract][Full Text] [Related]
19. Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.
Omboni S; Malacco E; Mallion JM; Fabrizzi P; Volpe M
High Blood Press Cardiovasc Prev; 2014 Mar; 21(1):1-19. PubMed ID: 24435506
[TBL] [Abstract][Full Text] [Related]
20. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
Matsui Y; Eguchi K; O'Rourke MF; Ishikawa J; Miyashita H; Shimada K; Kario K
Hypertension; 2009 Oct; 54(4):716-23. PubMed ID: 19667251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
